ILLUCCIX
Google image searchProduct monograph
Active ingredient
gallium (68ga) gozetotide, 25 MCG/VIAL
DIN: 02531836
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Schedule C
Company: TELIX PHARMACEUTICALS (US), INC.
Date: 03-APR-2023
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09I — TUMOUR DETECTION (ATC, ATC/DDD)
- V09IX — Other diagnostic radiopharmaceuticals for tumour detection (ATC, ATC/DDD)
- V09IX14 — GALLIUM (68Ga) GOZETOTIDE (ATC/DDD)
